Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

Porter, Kholoud; Babiker, Abdel G.; Bhaskaran, Krishnan; Darbyshire, Janet; Pezzotti, Patrizio; Walker, A. Sarah

doi:10.1016/s0140-6736(03)14570-9

Record: found
Abstract: found
Article: not found

Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

Author(s): Kholoud Porter ¹ , Abdel Babiker , Krishnan Bhaskaran , Janet Darbyshire , Patrizio Pezzotti , Kholoud Porter , A Sarah Walker

Publication date (Electronic): Oct 18 2003

Journal: Lancet (London, England)

Publisher: Elsevier BV

Read this article at

ScienceOpenPublisher PubMed

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Highly active antiretroviral therapy (HAART) was introduced in 1997. We aimed to assess the continuing effect of this treatment on survival and progression to AIDS after HIV-1 seroconversion.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Lancet

Title: Lancet (London, England)

Publisher: Elsevier BV

ISSN (Electronic): 1474-547X

ISSN (Print): 0140-6736

Publication date (Electronic): Oct 18 2003

Volume: 362

Issue: 9392

Affiliations

[1 ] Clinical Trials Unit, 222 Euston Road, , London NW1 2DA, UK. kp@ctu.mrc.ac.uk

Article

Publisher Item ID: S0140673603145709

DOI: 10.1016/s0140-6736(03)14570-9

PubMed ID: 14575971

SO-VID: d756cfd0-d694-4222-a7dc-0da167c6c4ff

History

Data availability:

Comments

Comment on this article

Cited by 52

See all cited by

- Version 1

Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

Read this article at

Abstract

Related collections

An Introduction to SAXS

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 249

Cited by 52